Shell Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.73M | Sell |
22,264
-38,908
| -64% | -$3.04M | 0.17% | 124 |
|
|
2025
Q2 | $4.78M | Buy |
61,172
+19,014
| +45% | +$1.42M | 0.17% | 120 |
|
|
2025
Q1 | $3.06M | Sell |
42,158
-1,861
| -4% | -$133K | 0.15% | 140 |
|
|
2024
Q4 | $3.26M | Sell |
44,019
-833
| -2% | -$58.3K | 0.14% | 135 |
|
|
2024
Q3 | $2.96M | Buy |
+44,852
| New | +$3.26M | 0.13% | 150 |
|
|
2024
Q1 | $3.23M | Sell |
34,983
-15,037
| -30% | -$1.26M | 0.15% | 130 |
|
|
2023
Q4 | $3.81M | Sell |
50,020
-13,056
| -21% | -$908K | 0.18% | 115 |
|
|
2023
Q3 | $4.37M | Sell |
63,076
-1,234
| -2% | -$99.2K | 0.18% | 112 |
|
|
2023
Q2 | $6.07M | Sell |
64,310
-8,376
| -12% | -$728K | 0.24% | 75 |
|
|
2023
Q1 | $6.01M | Buy |
72,686
+1,310
| +2% | +$103K | 0.25% | 80 |
|
|
2022
Q4 | $5.33M | Buy |
71,376
+18,103
| +34% | +$1.4M | 0.23% | 88 |
|
|
2022
Q3 | $4.4M | Sell |
53,273
-13,254
| -20% | -$1.28M | 0.17% | 126 |
|
|
2022
Q2 | $6.33M | Buy |
66,527
+931
| +1% | +$96.4K | 0.19% | 121 |
|
|
2022
Q1 | $7.72M | Sell |
65,596
-21,000
| -24% | -$2.36M | 0.18% | 117 |
|
|
2021
Q4 | $11.2M | Buy |
86,596
+8,245
| +11% | +$962K | 0.23% | 87 |
|
|
2021
Q3 | $8.87M | Buy |
78,351
+1,536
| +2% | +$175K | 0.2% | 113 |
|
|
2021
Q2 | $7.96M | Sell |
76,815
-3,665
| -5% | -$345K | 0.15% | 146 |
|
|
2021
Q1 | $6.73M | Buy |
80,480
+4,055
| +5% | +$343K | 0.13% | 178 |
|
|
2020
Q4 | $6.97M | Buy |
76,425
+15,185
| +25% | +$1.26M | 0.14% | 165 |
|
|
2020
Q3 | $4.89M | Sell |
61,240
-12,088
| -16% | -$943K | 0.11% | 190 |
|
|
2020
Q2 | $5.07M | Sell |
73,328
-20,524
| -22% | -$1.46M | 0.13% | 181 |
|
|
2020
Q1 | $5.9M | Sell |
93,852
-10,848
| -10% | -$782K | 0.16% | 157 |
|
|
2019
Q4 | $8.14M | Buy |
104,700
+24,276
| +30% | +$1.9M | 0.18% | 154 |
|
|
2019
Q3 | $5.89M | Sell |
80,424
-2,406
| -3% | -$169K | 0.13% | 188 |
|
|
2019
Q2 | $5.1M | Buy |
82,830
+11,457
| +16% | +$693K | 0.11% | 218 |
|
|
2019
Q1 | $4.55M | Hold |
71,373
| – | – | 0.1% | 233 |
|
|
2018
Q4 | $3.64M | Sell |
71,373
-39,522
| -36% | -$2M | 0.09% | 246 |
|
|
2018
Q3 | $6.44M | Buy |
110,895
+10,110
| +10% | +$494K | 0.13% | 193 |
|
|
2018
Q2 | $4.89M | Sell |
100,785
-1,035
| -1% | -$48.3K | 0.1% | 238 |
|
|
2018
Q1 | $4.74M | Buy |
101,820
+750
| +0.7% | +$32.6K | 0.09% | 239 |
|
|
2017
Q4 | $3.8M | Buy |
101,070
+13,308
| +15% | +$488K | 0.08% | 271 |
|
|
2017
Q3 | $3.2M | Buy |
87,762
+29,814
| +51% | +$1.14M | 0.07% | 283 |
|
|
2017
Q2 | $2.28M | Sell |
57,948
-60,648
| -51% | -$2.21M | 0.05% | 348 |
|
|
2017
Q1 | $3.72M | Sell |
118,596
-29,592
| -20% | -$926K | 0.08% | 262 |
|
|
2016
Q4 | $4.63M | Buy |
148,188
+5,526
| +4% | +$179K | 0.11% | 216 |
|
|
2016
Q3 | $5.73M | Buy |
+142,662
| New | +$5.37M | 0.12% | 208 |
|
Other funds holding EW
Shell Asset Management's EW Position: Q3 2025 in Review
Shell Asset Management reduced its Edwards Lifesciences (EW) stake by 64% in Q3 2025, selling an estimated $3.04M and leaving 22,264 shares worth $1.73M. The position accounts for 0.17% of the portfolio, ranked #124.
Shell Asset Management first reported a position in EW in Q3 2016 and has held it in 36 quarters since. The position peaked at $11.2M in Q4 2021. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.
- Shell Asset Management held 22,264 shares of Edwards Lifesciences worth $1.73M as of Q3 2025.
- Shell Asset Management sold 38,908 Edwards Lifesciences shares in Q3 2025, an estimated $3.04M.
- Edwards Lifesciences made up 0.17% of Shell Asset Management's portfolio in Q3 2025, its #124 holding.
- Shell Asset Management first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 36 quarters since.
- Shell Asset Management's Edwards Lifesciences position peaked at $11.2M in Q4 2021.
- 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.